From the Journals

Polypharmacy common among patients aged 65 or older with HIV


 

FROM THE CANADIAN JOURNAL OF GENERAL INTERNAL MEDICINE

‘Carefully document medications’

“This study identifies potentially inappropriate medication use in a group of older people living with HIV who are particularly vulnerable to it at an earlier age because of their medical complexity or frailty than perhaps healthy older adults,” Adrian Wagg, MD, professor of healthy aging in the department of medicine at the University of Alberta, Edmonton, told this news organization.

The study emphasizes the importance of careful documentation of medications that the patient is taking at every clinical visit, he said.

“Make sure you carefully document medications which are taken whenever you see the individual. Also try to limit the number of prescribers, because we know multiple prescribers are associated with greater likelihood of inappropriate prescribing,” Dr. Wagg said.

The move to wean patients from inappropriate medications is gaining momentum, he added.

“There is a huge movement now around actively deprescribing medications which are either no longer indicated or potentially of little benefit, given remaining life expectancy,” said Dr. Wagg. Drugs such as proton pump inhibitors, hypnotics, unrequired antidepressants, and benzodiazepines are the first targets for elimination, he concluded.

The study was funded by the University of Calgary. Dr. McMillan and Dr. Wagg reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

HIV: Dual therapy with twice-yearly injections on the horizon
MDedge Infectious Disease
HIV Management: Insights Into ART and Weight Gain
MDedge Infectious Disease
Honoring Dr. Paul Farmer: Dr. Serena Koenig shares her memories of working with him
MDedge Infectious Disease
MSM have higher CD4 counts at HIV diagnosis than heterosexuals
MDedge Infectious Disease
Schizophrenia and HIV: missed opportunities for care
MDedge Infectious Disease
Antiretroviral therapy associated with less risk of preterm birth
MDedge Infectious Disease
More questions than answers when managing HIV and menopause
MDedge Infectious Disease
FDA approves HIV injectable Cabenuva initiation without oral lead-in
MDedge Infectious Disease
Protease inhibitors increase small-for-gestational-age but not other pregnancy risks
MDedge Infectious Disease
Counterfeit HIV drugs: Justice Department opens investigation
MDedge Infectious Disease